Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Prudential Financial Inc (PRU) Price & Performance

AbCellera Biologics IncTrade
Prudential Financial IncTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Prudential Financial Inc — how do they compare? AbCellera Biologics Inc trades at $8.93 (market cap $2.99B), while Prudential Financial Inc trades at $122.19 (market cap $42.20B). The key difference: Prudential Financial Inc is far larger — about 14.1× AbCellera Biologics Inc's market cap, and Prudential Financial Inc pays a 4.58% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLPRU
Market Cap
$2.99B$42.20B
Sector
HealthFinancials
52-Week High
$9.76$123.93
52-Week Low
$2.78$92.00
Enterprise Value
$2.58B$70.98B
Dividend Yield
4.58%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Prudential Financial Inc

Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.

Read more on PRU